Delivery Order SPE2DB20D1109-SPE2DB22FP77M
Award Date 8/4/22
Potential Completion Date 8/5/22
Potential Value $4.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,596.37 for the supply of Micardis HCT 80-12.5 mg tablets. The award was made by the Defense Logistics Agency (DLA) and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,301.18 for the supply of Micardis HCT 80-25 mg tablet medication. The award was made by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, and has an ultimate completion date of January 27, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $5,363.78 for Micardis HCT 80-25 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 13, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as...
- This federal contract award is for pharmaceutical products and medical supplies provided by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $11,347.43 delivery order contract with the Defense Logistics Agency (DLA) is for Micardis HCT 40-12.5 mg tablets and has a completion date of May 3, 2023. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) was issued by the Defense Logistics Agency (DLA) under contract number SPE2DB20D2104|SPE2DB22FS44Y. The $2,645.04 firm fixed-price delivery order is for the supply of Micardis HCT 40-12.5 mg tablets. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a pharmaceutical product. The $13,607.57 delivery order contract has a performance period through May 7, 2024 and utilizes a firm fixed price pricing type. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $6,183.14 firm fixed-price delivery order for the supply of MICARDIS HCT 80-12.5 MG TABLET UD 30S. The award, issued by the Defense Logistics Agency (DLA), has an ultimate completion date of November 23, 2021. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver...
- This federal contract award is for the delivery of Micardis HCT 80-25 mg tablet medication to the Defense Logistics Agency (DLA). The $2,494.96 delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distributor Cencora, Inc. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The DO, valued at $2,246.82, is for the supply of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a pharmaceutical product. The IDC, valued at up to $999,999,999.00, enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific Delivery Order is for MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication,...